Pfizer Opens Analytics Gateway in India to Propel Growth

Pfizer opens Analytics Gateway in India, a capability centre to propel growth with talent and innovation

Overview

Pfizer Inc. has launched the company’s first ever dedicated commercial analytics centre in India called, ‘the Analytics Gateway’. The Analytics Gateway represents a significant milestone in Pfizer’s international commercial strategy and is positioned to be a global capability centre serving all of Pfizer’s international (ex-US) markets to bring analytics, and insight breakthroughs that will benefit patients.

The Analytics Gateway

• The Analytics Gateway comprises a talented and experienced pool of data and analytics experts. 
• The centre that is set up in Mumbai, is expected to accelerate data science and AI solutions to meet Pfizer’s ambitions in modernizing marketing and creating an agile sales force. 
• It will also drive continuous commercial effectiveness, enabling Pfizer to bring more of its medicines to more patients in India and around the world.

Statement from the CCA, Pfizer

Xingchu Liu, chief commercial analytics & AI officer, said, “The Analytics Gateway is an important catalyst to reshape healthcare, transforming how we deliver breakthroughs at lightspeed, enabling us to deliver life-changing therapies to patients. We are confident that the setup of this capability centre in India will have a positive impact on Pfizer’s ability to make informed, data-driven decisions that will prove valuable to patients and customers around the world.”

Statement from Pfizer India

Meenakshi Nevatia, country president, Pfizer India, said, “The launch of Analytics Gateway in India is an important recognition of the skilled talent in data science and analytics that our country can offer to the globe. It strengthens the company’s presence in India.  The actionable insights generated by the Analytics Gateway will power up our global commercial engine as we modernize healthcare to meet the evolving needs of patients in India and worldwide and deliver strong patient outcomes.

Optimize Your trial insights with Clival Database.

Are you exhausted from the uncertainty of trial insights pricing? Clival Database ensures the clarity in the midst of the global scenario for clinical trials to you.

Clival Database is one of the best databases that offers an outstanding number of clinical trial data in terms of 50,000+ molecules and from primary regulatory markets as well as new entrants like Indian and Chinese markets.

With Clival, you get accurate positioning of historical sales data, patent database, company profiling, safety & efficacy, and prediction of launch of new innovative molecules helping you to align your research and driving down the cost.

To add value, we further break down our analytics for you so that improving your operational effectiveness; optimizing your clinical trials; and offering you accurate and high-quality data at lowest possible prices becomes possible.

Elevate your trial success rate with the cutting-edge insights from Clival database.

Check it out today and make more informed sourcing decisions! Learn More!